Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38388646

Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leukemia
Publication date
2024 Apr
First author
Chang L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Chang L
      type
      Author
    2. name
      Lang M
      type
      Author
    3. name
      Lin H
      type
      Author
    4. name
      Cai H
      type
      Author
    5. name
      Duan MH
      type
      Author
    6. name
      Zhou DB
      type
      Author
    7. name
      Cao XX
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Chang L
      type
      Author
    2. name
      Lang M
      type
      Author
    3. name
      Lin H
      type
      Author
    4. name
      Cai H
      type
      Author
    5. name
      Duan MH
      type
      Author
    6. name
      Zhou DB
      type
      Author
    7. name
      Cao XX
      type
      Author
    bibliography ids
    1. nci-bib-ae28c246c0b5b53cc9995883
    book metadata
    content sha256
    cf072ce9ff4de3b9df766f8dd4d7fda73836b3be3d8f54d0be3484b376dc739c
    document type
    citation
    dois
    1. 10.1038/s41375-024-02174-1
    electronic publication date
    display
    2024 Feb 22
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:38388646
    immutable id
    pubmed:38388646@cf072ce9ff4de3b9df766f8dd4d7fda73836b3be3d8f54d0be3484b376dc739c
    journal
    abbreviation
    Leukemia
    issn electronic
    1476-5551
    issn print
    0887-6924
    issue
    4
    name
    Leukemia
    nlm unique id
    8704895
    pages
    803-809
    volume
    38
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      38388646
      provenance
      batch id
      6d213eecf21b6b7867cb
      provider
      NCBI PubMed ESummary
      record sha256
      28914e4ce510dafe1db15fb5f773282a166c1c0fa965b271ef6cae7ef59f4a52
      response sha256
      684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
      retrieved at
      2026-09-09T23:48:19.049083+00:00
      publication date
      display
      2024 Apr
      precision
      month
      year
      2024
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/38388646/
      title
      Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis.

      Preserved source evidence · Not medical advice